Find Oxatomide manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

API REF. PRICE (USD/KG)

MARKET PLACE

0

API

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 60607-34-3, Tinset, Celtect, Cobiona, Dasten, Kw-4354
Molecular Formula
C27H30N4O
Molecular Weight
426.6  g/mol
InChI Key
BAINIUMDFURPJM-UHFFFAOYSA-N
FDA UNII
J31IL9Z2EE

Oxatomide
Oxatomide has been used in trials studying the treatment of Muscular Dystrophy, Duchenne.
1 2D Structure

Oxatomide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-[3-(4-benzhydrylpiperazin-1-yl)propyl]-1H-benzimidazol-2-one
2.1.2 InChI
InChI=1S/C27H30N4O/c32-27-28-24-14-7-8-15-25(24)31(27)17-9-16-29-18-20-30(21-19-29)26(22-10-3-1-4-11-22)23-12-5-2-6-13-23/h1-8,10-15,26H,9,16-21H2,(H,28,32)
2.1.3 InChI Key
BAINIUMDFURPJM-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CN(CCN1CCCN2C3=CC=CC=C3NC2=O)C(C4=CC=CC=C4)C5=CC=CC=C5
2.2 Other Identifiers
2.2.1 UNII
J31IL9Z2EE
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Kw 4354

2. Kw-4354

3. Oxatimide

4. R 35443

5. R35443

6. Tinset

2.3.2 Depositor-Supplied Synonyms

1. 60607-34-3

2. Tinset

3. Celtect

4. Cobiona

5. Dasten

6. Kw-4354

7. 3-[3-(4-benzhydrylpiperazin-1-yl)propyl]-1h-benzimidazol-2-one

8. 1-[3-[4-(diphenylmethyl)-1-piperazinyl]propyl]-1,3-dihydro-2h-benzimidazol-2-one

9. R-35443

10. R 35,443

11. 1-(3-(4-benzhydrylpiperazin-1-yl)propyl)-1h-benzo[d]imidazol-2(3h)-one

12. Oxatimide

13. Nsc-309710

14. 1-(3-(4-(diphenylmethyl)-1-piperazinyl)propyl)-2-benzimidazolinone

15. J31il9z2ee

16. 1-(3-(4-(diphenylmethyl)-1-piperazinyl)propyl)-1,3-dihydro-2h-benzimidazol-2-one

17. Mls000028549

18. Oxatomidum

19. Oxatomida

20. Ncgc00015774-03

21. Smr000058301

22. 1-[3-[4-(diphenylmethyl)-1-piperazinyl]propyl]-2-benzimidazolinone

23. Oxatomidum [inn-latin]

24. 2h-benzimidazol-2-one, 1-(3-(4-(diphenylmethyl)-1-piperazinyl)propyl)-1,3-dihydro-

25. Dsstox_cid_25181

26. Dsstox_rid_80729

27. Dsstox_gsid_45181

28. Oxatomida [inn-spanish]

29. Mcn-jr 35443

30. R 35443

31. Celtect (tn)

32. Cas-60607-34-3

33. Einecs 262-320-9

34. Cbmicro_024634

35. Unii-j31il9z2ee

36. Brn 4724760

37. Oxatomide (jan/usan/inn)

38. 1-{3-[4-(diphenylmethyl)-1-piperazinyl]propyl}-1,3-dihydro-2h-benzimidazol-2-one

39. Oxatomide [usan:inn:ban:jan]

40. Oxatomide, >=99%

41. Oxatomide [inn]

42. Oxatomide [jan]

43. Oxatomide [mi]

44. Oxatomide [usan]

45. Lopac-o-9387

46. Oxatomide [mart.]

47. O 9387

48. Cid_4615

49. Oxatomide [who-dd]

50. Lopac0_000924

51. Oprea1_338592

52. Regid_for_cid_4615

53. Schembl28824

54. Chembl13828

55. Dtxsid4045181

56. Bdbm76863

57. Chebi:31943

58. Hms2089n07

59. Hms2231h12

60. Hms3372k08

61. Tox21_110219

62. Ccg-11811

63. Nsc309710

64. Nsc771641

65. Zinc19632896

66. Akos000507212

67. Tox21_110219_1

68. Ab04841

69. Db12877

70. Ks-1375

71. Nsc 309710

72. Nsc-771641

73. 2h-benzimidazol-2-one, 1,3-dihydro-1-(3-(4-(diphenylmethyl)-1-piperazinyl)propyl)-

74. Ncgc00015774-01

75. Ncgc00015774-02

76. Ncgc00015774-04

77. Ncgc00015774-05

78. Ncgc00015774-06

79. Ncgc00094235-01

80. Ncgc00094235-02

81. Bim-0024581.p001

82. Db-053668

83. Hy-123205

84. Cs-0081837

85. Eu-0100924

86. Ft-0630723

87. D01773

88. Ab01227629-02

89. 607o343

90. A832804

91. Sr-01000076051

92. Q2071515

93. Sr-01000076051-1

94. W-105243

95. 3-[3-(4-benzhydrylpiperazino)propyl]-1h-benzimidazol-2-one

96. 3-[3-[4-(diphenylmethyl)-1-piperazinyl]propyl]-1h-benzimidazol-2-one

97. 3-[3-[4-(diphenylmethyl)piperazin-1-yl]propyl]-1h-benzimidazol-2-one

98. 1-[3-(4-benzhydrylpiperazin-1-yl)propyl]-1,3-dihydro-2h-benzimidazol-2-one

99. 1-{3-[4-(diphenylmethyl)-1-piperazinyl}-propyl}-1,3-dihydro-2h-benzimidazol-2-one

100. 1{-[4-(diphenylmethyl)-1-piperzinyl]propyl}-1,3-dihydro-2h-benzimidazol-2-one

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 426.6 g/mol
Molecular Formula C27H30N4O
XLogP34.1
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count7
Exact Mass426.24196159 g/mol
Monoisotopic Mass426.24196159 g/mol
Topological Polar Surface Area38.8 Ų
Heavy Atom Count32
Formal Charge0
Complexity575
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Asthmatic Agents

Drugs that are used to treat asthma. (See all compounds classified as Anti-Asthmatic Agents.)


Histamine H1 Antagonists

Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)


Anti-Allergic Agents

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)


4.2 ATC Code

R - Respiratory system

R06 - Antihistamines for systemic use

R06A - Antihistamines for systemic use

R06AE - Piperazine derivatives

R06AE06 - Oxatomide


API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"OXATOMIDE","year":"2021","qtr":"Q1","strtotime":1611167400,"product":"PHARMACEUTICAL ALLOPATHIC RAW MATERIAL (2001261167 & 12.01.2021) OXATOMIDE IHS NOC NO: 3618\/A3\/2020 DT: 19.10.2020***","address":"78\/A,VENGALARAO NAGARHYDERABAD","city":"ANDHRA PRADESH","supplier":"VASUDHA PHARMA CHEM","supplierCountry":"INDIA","foreign_port":"KARACHI -","customer":"TO THE ORDER OF","customerCountry":"PAKISTAN","quantity":"50.00","actualQuantity":"50","unit":"KGS","unitRateFc":"191.5","totalValueFC":"9696.8","currency":"USD","unitRateINR":14183.799999999999,"date":"21-Jan-2021","totalValueINR":"709190","totalValueInUsd":"9696.8","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"8059781","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"78\/A,VENGALARAO NAGARHYDERABAD, ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1627237800,"product":"ACTIVE PHARMACEUTICAL INGREDIENT 2101260 422 & 22.07.2021 OXATOMIDE IH (NOC NO.11 97946\/TS\/2021 DT 30.04.2021)","address":"78\/A,VENGALARAO NAGARHYDERABAD","city":"ANDHRA PRADESH","supplier":"VASUDHA PHARMA CHEM","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"TO THE ORDER OF","customerCountry":"TAIWAN","quantity":"16.00","actualQuantity":"16","unit":"KGS","unitRateFc":"247.4","totalValueFC":"3826.8","currency":"USD","unitRateINR":17824.973125,"date":"26-Jul-2021","totalValueINR":"285199.57","totalValueInUsd":"3826.8","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"3393171","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"78\/A,VENGALARAO NAGARHYDERABAD, ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1681237800,"product":"BULK DRUG: OXATOMIDE ANHYDROUS","address":"SURVEY NO 270 WORKS 1 SURVEY NO 27 0,NAWABPET VILLAGE SHIVAMPET MANDAL","city":"HYDERABAD,TELANGANA","supplier":"FLEMING LABORATORIES","supplierCountry":"INDIA","foreign_port":"JAKARTA","customer":"PT NARDA TITA","customerCountry":"INDONESIA","quantity":"9.00","actualQuantity":"9","unit":"KGS","unitRateFc":"350","totalValueFC":"3038.3","currency":"USD","unitRateINR":27666.666666666668,"date":"12-Apr-2023","totalValueINR":"249000","totalValueInUsd":"3038.3","indian_port":"HYDERABAD AIR","hs_no":"29335990","bill_no":"9246422","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"INDONESIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"SURVEY NO 270 WORKS 1 SURVEY NO 27 0,NAWABPET VILLAGE SHIVAMPET MANDAL, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1683311400,"product":"ACTIVE PHARMACEUTICAL INGREDIENT NOC LIC NO 4110754 TS 2023 DT 24 03 2023 OXATOMIDE IH OR OXATOMIDE ANHYDROUS IN HOUSE","address":"78\/A,VENGALARAO NAGAR,HYDERABAD","city":"HYDERABAD,TELANGANA","supplier":"VASUDHA PHARMA CHEM","supplierCountry":"INDIA","foreign_port":"BASLE","customer":"TO THE ORDER","customerCountry":"SWITZERLAND","quantity":"150.00","actualQuantity":"150","unit":"KGS","unitRateFc":"177.2","totalValueFC":"25776.5","currency":"USD","unitRateINR":14140,"date":"06-May-2023","totalValueINR":"2121000","totalValueInUsd":"25776.5","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"SWITZERLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"78\/A,VENGALARAO NAGAR,HYDERABAD, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1683829800,"product":"PHARMACEUTICAL ALLOPATHIC RAW MATERIAL 2301260143 09 05 2023 OXATOMIDE IN HOUSE NOC LIC NO 3946981 TS 2023 DT 2","address":"78\/A,VENGALARAO NAGAR,HYDERABAD","city":"HYDERABAD,TELANGANA","supplier":"VASUDHA PHARMA CHEM","supplierCountry":"INDIA","foreign_port":"KARACHI","customer":"TO THE ORDER","customerCountry":"PAKISTAN","quantity":"100.00","actualQuantity":"100","unit":"KGS","unitRateFc":"190","totalValueFC":"18448.3","currency":"USD","unitRateINR":15180,"date":"12-May-2023","totalValueINR":"1518000","totalValueInUsd":"18448.3","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"78\/A,VENGALARAO NAGAR,HYDERABAD, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1684866600,"product":"ACTIVE PHARMACEUTICAL INGREDIENT 2301260181 DATE 19 05 2023 OXATOMIDE IH VIDE EXPORT NOC NO 4068878 TS 2023 DATE 08 03","address":"78\/A,VENGALARAO NAGAR,HYDERABAD","city":"HYDERABAD,TELANGANA","supplier":"VASUDHA PHARMA CHEM","supplierCountry":"INDIA","foreign_port":"TOKYO NARITA","customer":"TO THE ORDER","customerCountry":"JAPAN","quantity":"1.50","actualQuantity":"1.5","unit":"KGS","unitRateFc":"199","totalValueFC":"267.4","currency":"USD","unitRateINR":14666.666666666666,"date":"24-May-2023","totalValueINR":"22000","totalValueInUsd":"267.4","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"78\/A,VENGALARAO NAGAR,HYDERABAD, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724869800,"product":"OXATOMIDE (REF NO: 2401260531 DATE: 26.08.2024)(NOC NO:NOC\/24\/000318 DT:06\/06\/2024&LIC NO: 4261520\/TS\/2024 DT:18.06.2024","address":"78\/A,VENGALARAO NAGAR","city":"ANDHRA PRADESH","supplier":"VASUDHA PHARMA CHEM","supplierCountry":"INDIA","foreign_port":"JAKARTA SOEKARNO-HA","customer":"PT.GUARDIAN PHARMATAMA","customerCountry":"INDONESIA","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"475","totalValueFC":"4614.8","currency":"USD","unitRateINR":38708.158000000003,"date":"29-Aug-2024","totalValueINR":"387081.58","totalValueInUsd":"4614.8","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"3583357","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"INDONESIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"78\/A,VENGALARAO NAGAR, ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1726338600,"product":"OXATOMIDE (EXP.REF NO:2401260614 DT:12.09.2024)(NOC-EXPORT\/2024\/001037 DT:26.06.2024 & LIC. NO:4262916\/TS\/2024 DT:16.07.","address":"78\/A,VENGALARAO NAGAR","city":"ANDHRA PRADESH","supplier":"VASUDHA PHARMA CHEM","supplierCountry":"INDIA","foreign_port":"BASLE","customer":"AIRPHARM","customerCountry":"SWITZERLAND","quantity":"150.00","actualQuantity":"150","unit":"KGS","unitRateFc":"177.2","totalValueFC":"25735.2","currency":"USD","unitRateINR":14377.604866666667,"date":"15-Sep-2024","totalValueINR":"2156640.73","totalValueInUsd":"25735.2","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"4028337","productDescription":"API","marketType":"REGULATED MARKET","country":"SWITZERLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"78\/A,VENGALARAO NAGAR, ANDHRA PRADESH","customerAddress":""}]
21-Jan-2021
15-Sep-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Global Sales Information

Do you need Business Intel? Ask us

ABOUT THIS PAGE

Oxatomide Manufacturers

A Oxatomide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxatomide, including repackagers and relabelers. The FDA regulates Oxatomide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxatomide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Oxatomide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Oxatomide Suppliers

A Oxatomide supplier is an individual or a company that provides Oxatomide active pharmaceutical ingredient (API) or Oxatomide finished formulations upon request. The Oxatomide suppliers may include Oxatomide API manufacturers, exporters, distributors and traders.

click here to find a list of Oxatomide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Oxatomide USDMF

A Oxatomide DMF (Drug Master File) is a document detailing the whole manufacturing process of Oxatomide active pharmaceutical ingredient (API) in detail. Different forms of Oxatomide DMFs exist exist since differing nations have different regulations, such as Oxatomide USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Oxatomide DMF submitted to regulatory agencies in the US is known as a USDMF. Oxatomide USDMF includes data on Oxatomide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Oxatomide USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Oxatomide suppliers with USDMF on PharmaCompass.

Oxatomide JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Oxatomide Drug Master File in Japan (Oxatomide JDMF) empowers Oxatomide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Oxatomide JDMF during the approval evaluation for pharmaceutical products. At the time of Oxatomide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Oxatomide suppliers with JDMF on PharmaCompass.

Oxatomide KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Oxatomide Drug Master File in Korea (Oxatomide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Oxatomide. The MFDS reviews the Oxatomide KDMF as part of the drug registration process and uses the information provided in the Oxatomide KDMF to evaluate the safety and efficacy of the drug.

After submitting a Oxatomide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Oxatomide API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Oxatomide suppliers with KDMF on PharmaCompass.

Oxatomide WC

A Oxatomide written confirmation (Oxatomide WC) is an official document issued by a regulatory agency to a Oxatomide manufacturer, verifying that the manufacturing facility of a Oxatomide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Oxatomide APIs or Oxatomide finished pharmaceutical products to another nation, regulatory agencies frequently require a Oxatomide WC (written confirmation) as part of the regulatory process.

click here to find a list of Oxatomide suppliers with Written Confirmation (WC) on PharmaCompass.

Oxatomide GMP

Oxatomide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Oxatomide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxatomide GMP manufacturer or Oxatomide GMP API supplier for your needs.

Oxatomide CoA

A Oxatomide CoA (Certificate of Analysis) is a formal document that attests to Oxatomide's compliance with Oxatomide specifications and serves as a tool for batch-level quality control.

Oxatomide CoA mostly includes findings from lab analyses of a specific batch. For each Oxatomide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Oxatomide may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxatomide EP), Oxatomide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxatomide USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty